Intranasal Nalmefene (Orexo)

鼻吸入纳美芬 (Orexo)

Report date: 2024/11/04 15:26:25

Base Information

Drug NameIntranasal Nalmefene (Orexo)
Drug Alias NameOX125OX-125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonistsδ-opioid receptor antagonistsKappa opioid receptor agonists
TargetsMu opioid receptorδ-opioid receptorKappa opioid receptor
Therapy Area/IndicationsOpioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrexo Us Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrexo Us Inc
Inactive CompaniesN/A
Active IndicationsOpioid-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank